FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Marc Levesque

Research Profile

Disorders

Chemicals & Drugs

Anatomy

Geographic Areas

Tanzania

Genes & Molecular Sequences

Alleles

Concepts & Ideas

Co-author Network

Publications

TOP 3
E William St Clair; Frederick B Vivino; Josiah Wedgwood; Chacko J Alappatt; Philip Cohen; Lytia Fisher; Marc C Levesque; James McNamara; Kathy L Moser Sivils; Eline T Luning Prak; Meagan E Spychala
Rituximab therapy for primary Sjögren's syndrome: an open-label clinical trial and mechanistic analysis.
Rehan A Kahloon; Naftali Kaminski; Daniel J Kass; Marc C Levesque; Kathleen O Lindell; Chester V Oddis; Leo Otterbein; Joseph M Pilewski; Frank C Sciurba; Makoto Soejima; Jianmin Xue; Yingze Zhang; Gunjan Banga; Arpit Bhargava; Jessica Bon; Eva Csizmadia; Michael P Donahoe; Kevin F Gibson; Steven R Duncan
Patients with idiopathic pulmonary fibrosis with antibodies to heat shock protein 70 have poor prognoses.
Chester V Oddis; Sherrie L Pryber; Ann M Reed; Lisa G Rider; Howard E Rockette; Rohit Aggarwal; Dana Ascherman; Richard J Barohn; Brian M Feldman; Noreen Fertig; Michael O Harris-Love; Stephanie S Kelley; Diane C Koontz; Marc C Levesque; Frederick W Miller
Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trial.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Marc Levesque (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: E William St Clair; Frederick B Vivino; Josiah Wedgwood; Chacko J Alappatt; Philip Cohen; Lytia Fisher; Marc C Levesque; James McNamara; Kathy L Moser Sivils; Eline T Luning Prak; Meagan E Spychala
Rituximab therapy for primary Sjögren's syndrome: an open-label clinical trial and mechanistic analysis.
Arthritis and rheumatism 2013;65(4):1097-106.
2013: Rehan A Kahloon; Naftali Kaminski; Daniel J Kass; Marc C Levesque; Kathleen O Lindell; Chester V Oddis; Leo Otterbein; Joseph M Pilewski; Frank C Sciurba; Makoto Soejima; Jianmin Xue; Yingze Zhang; Gunjan Banga; Arpit Bhargava; Jessica Bon; Eva Csizmadia; Michael P Donahoe; Kevin F Gibson; Steven R Duncan
Patients with idiopathic pulmonary fibrosis with antibodies to heat shock protein 70 have poor prognoses.
American journal of respiratory and critical care medicine 2013;187(7):768-75.
2013: Chester V Oddis; Sherrie L Pryber; Ann M Reed; Lisa G Rider; Howard E Rockette; Rohit Aggarwal; Dana Ascherman; Richard J Barohn; Brian M Feldman; Noreen Fertig; Michael O Harris-Love; Stephanie S Kelley; Diane C Koontz; Marc C Levesque; Frederick W Miller
Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trial.
Arthritis and rheumatism 2013;65(2):314-24.
2012: Marc C Levesque
Biologic rheumatoid arthritis therapies: do we need more comparative effectiveness data?
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 2012;26(2):65-70.
2011: Aarat M Patel; Douglas Chew; Marc C Levesque; Daniel Lupash; Larry W Moreland
Cost-effectiveness of biologics compared with disease-modifying antirheumatic drugs in rheumatoid arthritis.
Current rheumatology reports 2011;13(5):381-2.
2011: Aarat M Patel; Douglas Chew; Marc C Levesque; Daniel Lupash; Larry W Moreland
Inhibition of spleen tyrosine kinase for rheumatoid arthritis.
Current rheumatology reports 2011;13(5):377-8.
2011: Aarat M Patel; Douglas Chew; Marc C Levesque; Daniel Lupash; Larry W Moreland
JAK inhibition in rheumatoid arthritis.
Current rheumatology reports 2011;13(5):379-80.
2011: Mark C Lanasa; J F Leis; Marc C Levesque; C Love; G E Marti; Kari G Rabe; Laura Rassenti; S L Slager; L G Spector; S S Strom; C M Vachon; J Brice Weinberg; J R Cerhan; S S Dave; M Glenn; Jon P Gockerman; L R Goldin; Barbara K Goodman; C A Hanson; N E Kay; S J Achenbach; S D Allgood; T G Call; N J Camp; N E Caporaso
Immunophenotypic and gene expression analysis of monoclonal B-cell lymphocytosis shows biologic characteristics associated with good prognosis CLL.
Leukemia 2011;25(9):1459-66.
2011: Marwa El Mourabet; Jana G Hashash; Nicholas H Sun; Mazen Issa; Jeffry A Katz; Miguel Regueiro; Arthur M Barrie; Leonard Baidoo; Marc B Schwartz; Jason M Swoger; Marc C Levesque; David G Binion
Clinical course of Crohn's disease following treatment of lymphoma.
Inflammatory bowel diseases 2011;17(6):1265-9.
2010: Marc C Levesque; Maurine R Hobbs; Charles W O'Loughlin; Jennifer A Chancellor; Youwei Chen; Ariana N Tkachuk; Jennifer Booth; Kistie B Patch; Sallie Allgood; Ann R Pole; Carolyn A Fernandez; Esther D Mwaikambo; Theonest K Mutabingwa; Michal Fried; Bess Sorensen; Patrick Duffy; Donald L Granger; Nicholas Anstey; J Brice Weinberg
Malaria severity and human nitric oxide synthase type 2 (NOS2) promoter haplotypes.
Human genetics 2010;127(2):163-82.
2010: Mark C Lanasa; S D Allgood; A D Volkheimer; Jon P Gockerman; John F Whitesides; Barbara K Goodman; Joseph O Moore; J Brice Weinberg; Marc C Levesque
Single-cell analysis reveals oligoclonality among 'low-count' monoclonal B-cell lymphocytosis.
Leukemia 2010;24(1):133-40.
2009: Masayuki Kuraoka; Dongmei Liao; Kaiyong Yang; Sallie D Allgood; Marc C Levesque; Garnett Kelsoe; Yoshihiro Ueda
Activation-induced cytidine deaminase expression and activity in the absence of germinal centers: insights into hyper-IgM syndrome.
Journal of immunology (Baltimore, Md. : 1950) 2009;183(5):3237-48.
2009: Marc C Levesque; Zhijie Zhou; Larry W Moreland
Anti-cyclic citrullinated peptide testing for the diagnosis of rheumatoid arthritis and the quest for improved sensitivity and predictive value.
Arthritis and rheumatism 2009;60(8):2211-5.
2009: Marc C Levesque
Translational Mini-Review Series on B Cell-Directed Therapies: Recent advances in B cell-directed biological therapies for autoimmune disorders.
Clinical and experimental immunology 2009;157(2):198-208.
2009: Marc C Levesque; M Anthony Moody; Kwan-Ki Hwang; Dawn J Marshall; John F Whitesides; Joshua D Amos; Thaddeus C Gurley; Sallie Allgood; Benjamin B Haynes; Nathan A Vandergrift; Steven Plonk; Daniel C Parker; Myron S Cohen; Georgia D Tomaras; Paul A Goepfert; George M Shaw; Joern schmitz; Joseph J Eron; Nicholas J Shaheen; Charles B Hicks; Hua-Xin Liao; Martin Markowitz; Garnett Kelsoe; David M Margolis; Barton F Haynes
Polyclonal B cell differentiation and loss of gastrointestinal tract germinal centers in the earliest stages of HIV-1 infection.
PLoS medicine 2009;6(7):e1000107.
2009: Mark C Lanasa; Sallie D Allgood; Karen M Bond; Jon P Gockerman; Marc C Levesque; J Brice Weinberg
Oligoclonal TRBV gene usage among CD8(+) T cells in monoclonal B lymphocytosis and CLL.
British journal of haematology 2009;145(4):535-7.
2008: David W Hauswirth; John S Sundy; Sabrena Mervin-Blake; Carolyn A Fernandez; Kistie B Patch; Katie M Alexander; Sallie Allgood; Patrice D McNair; Marc C Levesque
Normative values for exhaled breath condensate pH and its relationship to exhaled nitric oxide in healthy African Americans.
The Journal of allergy and clinical immunology 2008;122(1):101-6.
2008: Marc C Levesque; Dipak K Ghosh; Bethany E Beasley; Youwei Chen; Alicia D Volkheimer; Charles W O'Loughlin; Jon P Gockerman; Joseph O Moore; J Brice Weinberg
CLL cell apoptosis induced by nitric oxide synthase inhibitors: correlation with lipid solubility and NOS1 dissociation constant.
Leukemia research 2008;32(7):1061-70.
2008: Allison E Ashley-Koch; Laine Elliott; Melanie E Kail; Laura M De Castro; Jude Jonassaint; Terry L Jackson; Jennifer Price; Kenneth I Ataga; Marc C Levesque; J Brice Weinberg; Eugene P Orringer; Ann Collins; Jeffery Vance; Marilyn J Telen
Identification of genetic polymorphisms associated with risk for pulmonary hypertension in sickle cell disease.
Blood 2008;111(12):5721-6.
2008: Marc C Levesque; David W Hauswirth; Sabrena Mervin-Blake; Carolyn A Fernandez; Kistie B Patch; Katie M Alexander; Sallie Allgood; Patrice D McNair; Andrew S Allen; John S Sundy
Determinants of exhaled nitric oxide levels in healthy, nonsmoking African American adults.
The Journal of allergy and clinical immunology 2008;121(2):396-402.e3.
2008: Marc C Levesque; E William St Clair
B cell-directed therapies for autoimmune disease and correlates of disease response and relapse.
The Journal of allergy and clinical immunology 2008;121(1):13-21; quiz 22-3.
2007: J Brice Weinberg; Alicia D Volkheimer; Youwei Chen; Bethany E Beasley; Ning Jiang; Mark C Lanasa; Daphne Friedman; Gina Vaccaro; Catherine W Rehder; Carlos M DeCastro; David A Rizzieri; Louis F Diehl; Jon P Gockerman; Joseph O Moore; Barbara K Goodman; Marc C Levesque
Clinical and molecular predictors of disease severity and survival in chronic lymphocytic leukemia.
American journal of hematology 2007;82(12):1063-70.
2007: R John Looney; Betty Diamond; V Michael Holers; Marc C Levesque; Larry Moreland; Moon H Nahm; E William St Clair
Guidelines for assessing immunocompetency in clinical trials for autoimmune diseases.
Clinical immunology (Orlando, Fla.) 2007;123(3):235-43.
2007: Laine Elliott; Allison E Ashley-Koch; Laura M De Castro; Jude Jonassaint; Jennifer Price; Kenneth I Ataga; Marc C Levesque; J Brice Weinberg; James R Eckman; Eugene P Orringer; Jeffery Vance; Marilyn J Telen
Genetic polymorphisms associated with priapism in sickle cell disease.
British journal of haematology 2007;137(3):262-7.
2007: Alicia D Volkheimer; J Brice Weinberg; Bethany E Beasley; John F Whitesides; Jon P Gockerman; Joseph O Moore; Garnett Kelsoe; Barbara K Goodman; Marc C Levesque
Progressive immunoglobulin gene mutations in chronic lymphocytic leukemia: evidence for antigen-driven intraclonal diversification.
Blood 2007;109(4):1559-67.
2006: Bert K Lopansri; Nicholas Anstey; Gregory J Stoddard; Esther D Mwaikambo; Craig S Boutlis; Emiliana Tjitra; Helena Maniboey; Maurine R Hobbs; Marc C Levesque; J Brice Weinberg; Donald L Granger
Elevated plasma phenylalanine in severe malaria and implications for pathophysiology of neurological complications.
Infection and immunity 2006;74(6):3355-9.
2006: Marc C Levesque; Youwei Chen; Bethany E Beasley; Charles W O'Loughlin; Jon P Gockerman; Joseph O Moore; J Brice Weinberg
Chronic lymphocytic leukemia cell CD38 expression and inducible nitric oxide synthase expression are associated with serum IL-4 levels.
Leukemia research 2006;30(1):24-8.
2004: Marc C Levesque; J Brice Weinberg
The dichotomous role of nitric oxide in the pathogenesis of accelerated atherosclerosis associated with systemic lupus erythematosus.
Current molecular medicine 2004;4(7):777-86.
2003: Craig S Boutlis; Maurine R Hobbs; Robyn L Marsh; Mary A Misukonis; Ariana N Tkachuk; Moses Lagog; Jennifer Booth; Donald L Granger; Moses J Bockarie; Charles S Mgone; Marc C Levesque; J Brice Weinberg; Nicholas Anstey
Inducible nitric oxide synthase (NOS2) promoter CCTTT repeat polymorphism: relationship to in vivo nitric oxide production/NOS activity in an asymptomatic malaria-endemic population.
The American journal of tropical medicine and hygiene 2003;69(6):569-73.
2003: Bert K Lopansri; Nicholas Anstey; J Brice Weinberg; Gregory J Stoddard; Maurine R Hobbs; Marc C Levesque; Esther D Mwaikambo; Donald L Granger
Low plasma arginine concentrations in children with cerebral malaria and decreased nitric oxide production.
Lancet 2003;361(9358):676-8.
2003: Marc C Levesque; Mary A Misukonis; Charles W O'Loughlin; Youwei Chen; Bethany E Beasley; D L Wilson; David J Adams; R Silber; J Brice Weinberg
IL-4 and interferon gamma regulate expression of inducible nitric oxide synthase in chronic lymphocytic leukemia cells.
Leukemia 2003;17(2):442-50.
2003: Jim Oates; Marc C Levesque; Maurine R Hobbs; Erica Grace Smith; Ivan D Molano; Grier P Page; Bruce S Hill; J Brice Weinberg; Glinda S Cooper; Gary S Gilkeson
Nitric oxide synthase 2 promoter polymorphisms and systemic lupus erythematosus in african-americans.
The Journal of rheumatology 2003;30(1):60-7.
2002: Maurine R Hobbs; Venkatachalam Udhayakumar; Marc C Levesque; Jennifer Booth; Jacquelin M Roberts; Ariana N Tkachuk; Ann Pole; Hilary Coon; Simon K Kariuki; Bernard L Nahlen; Esther D Mwaikambo; Altaf L Lal; Donald L Granger; Nicholas Anstey; J Brice Weinberg
A new NOS2 promoter polymorphism associated with increased nitric oxide production and protection from severe malaria in Tanzanian and Kenyan children.
Lancet 2002;360(9344):1468-75.
2001: David J Adams; Marc C Levesque; J Brice Weinberg; K L Smith; James L Flowers; J Moore; O Michael Colvin; R Silber
Nitric oxide enhancement of fludarabine cytotoxicity for B-CLL lymphocytes.
Leukemia 2001;15(12):1852-9.
2001: Marc C Levesque; Charles W O'Loughlin; J Brice Weinberg
Use of serum-free media to minimize apoptosis of chronic lymphocytic leukemia cells during in vitro culture.
Leukemia 2001;15(8):1305-7.
2001: Marc C Levesque; Barton F Haynes
Activated T lymphocytes regulate hyaluronan binding to monocyte CD44 via production of IL-2 and IFN-gamma.
Journal of immunology (Baltimore, Md. : 1950) 2001;166(1):188-96.
2000: Marc C Levesque; D A Mackin; J A Fleming; E William St Clair
Serum levels of soluble CD44 in primary Sjögren's syndrome.
The Journal of rheumatology 2000;27(6):1444-9.
1999: Marc C Levesque; Maurine R Hobbs; Nicholas Anstey; T N Vaughn; J A Chancellor; Ann Pole; Douglas J Perkins; Mary A Misukonis; STEPHEN CHANOCK; Donald L Granger; J Brice Weinberg
Nitric oxide synthase type 2 promoter polymorphisms, nitric oxide production, and disease severity in Tanzanian children with malaria.
The Journal of infectious diseases 1999;180(6):1994-2002.
1999: Marc C Levesque; Barton F Haynes
TNFalpha and IL-4 regulation of hyaluronan binding to monocyte CD44 involves posttranslational modification of CD44.
Cellular immunology 1999;193(2):209-18.
1999: Marc C Levesque; F E Ward; D R Jeffery; J Brice Weinberg
Interferon-beta1A-induced polyarthritis in a patient with the HLA-DRB1*0404 allele.
Arthritis and rheumatism 1999;42(3):569-73.
1998: Marc C Levesque; Craig S Heinly; LP Whichard; Dhavalkumar D Patel
Cytokine-regulated expression of activated leukocyte cell adhesion molecule (CD166) on monocyte-lineage cells and in rheumatoid arthritis synovium.
Arthritis and rheumatism 1998;41(12):2221-9.
1997: Marc C Levesque; Barton F Haynes
Cytokine induction of the ability of human monocyte CD44 to bind hyaluronan is mediated primarily by TNF-alpha and is inhibited by IL-4 and IL-13.
Journal of immunology (Baltimore, Md. : 1950) 1997;159(12):6184-94.
1997: Ning-pu Liu; Wendy L Roberts; Laura P Hale; Marc C Levesque; Dhavalkumar D Patel; C L Lu; Glenn J Jaffe
Expression of CD44 and variant isoforms in cultured human retinal pigment epithelial cells.
Investigative ophthalmology & visual science 1997;38(10):2027-37.
1996: Peter J Conlon; C A Fischer; Marc C Levesque; Stephen R Smith; E W St Clair; Nancy B Allen; J A Fleming; D N Howell
Clinical, biochemical and pathological predictors of poor response to intravenous cyclophosphamide in patients with proliferative lupus nephritis.
Clinical nephrology 1996;46(3):170-5.
1996: Marilyn J Telen; M Udani; M K Washington; Marc C Levesque; E Lloyd; N Rao
A blood group-related polymorphism of CD44 abolishes a hyaluronan-binding consensus sequence without preventing hyaluronan binding.
The Journal of biological chemistry 1996;271(12):7147-53.
1996: Marc C Levesque; Barton F Haynes
In vitro culture of human peripheral blood monocytes induces hyaluronan binding and up-regulates monocyte variant CD44 isoform expression.
Journal of immunology (Baltimore, Md. : 1950) 1996;156(4):1557-65.
1995: Hua-Xin Liao; DM Lee; Marc C Levesque; Barton F Haynes
N-terminal and central regions of the human CD44 extracellular domain participate in cell surface hyaluronan binding.
Journal of immunology (Baltimore, Md. : 1950) 1995;155(8):3938-45.
1993: Hua-Xin Liao; Marc C Levesque; K Patton; B Bergamo; D Jones; M Anthony Moody; Marilyn J Telen; Barton F Haynes
Regulation of human CD44H and CD44E isoform binding to hyaluronan by phorbol myristate acetate and anti-CD44 monoclonal and polyclonal antibodies.
Journal of immunology (Baltimore, Md. : 1950) 1993;151(11):6490-9.